"
Team:Tufts/future
From 2014.igem.org
(Difference between revisions)
| Line 76: | Line 76: | ||
--- Intermission --- <br> | --- Intermission --- <br> | ||
7. Panel – Anna Kuchment, Dr. Robin Pierce, Dr. Andrew Camilli, Mark Mimee <br> | 7. Panel – Anna Kuchment, Dr. Robin Pierce, Dr. Andrew Camilli, Mark Mimee <br> | ||
| + | |||
| + | <object width="100%" height="100%" data="https://static.igem.org/mediawiki/2014/c/c5/Tufts_conference.pdf"> </object> | ||
</div> | </div> | ||
</html> | </html> | ||
Revision as of 05:12, 17 October 2014
This October, Tufts Synthetic Biology hosted a conference, The Future of Phage and Synthetic Biology, which brought together experts from academia, industry, and regulation to discuss and present on emerging research concerning the applications of phage - specifically bacteriophage therapy.
Application Scenarios
Techno-Moral Scenarios
Survey
Summary
The conference incorporates two main events. The first is a professional workshop, to be held under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage application and associated safety and regulatory considerations. This will be followed by a public forum to present and discuss the results and implications with a more general audience before shifting to guided and informal discussion.Public Forum
1. Opening Remarks – President Anthony Monaco2. Biology of Phage – Tufts Synthetic Biology
3. Phage History & Current Use – Anna Kuchment
4. Current Research: Natural Phage – Dr. Andrew Camilli
5. Current Research: Engineered Phage – Mark Mimee
6. Distributive Justice – Christopher Ghadban
--- Intermission ---
7. Panel – Anna Kuchment, Dr. Robin Pierce, Dr. Andrew Camilli, Mark Mimee
